Influence of Expression Plasmid of Connective Tissue Growth Factor and Tissue Inhibitor of Metalloproteinase-1 shRNA on Hepatic Precancerous Fibrosis in Rats |
Zhang, Qun
(Division of Infectious Diseases, Affiliated Zhongda Hospital of Southeast University)
Shu, Fu-li (Dept. Infectious Diseases, Affiliated Hospital of Luzhou Medical College) Jiang, Yu-Feng (Dept. Infectious Diseases, Affiliated Hospital of Luzhou Medical College) Huang, Xin-En (Dept. of Chemotherapy, Jiangsu Cancer Hospital & Research Institute) |
1 | Giannelli G, Mazzocca A, Fransvea E, et al (2011). Inhibiting TGF-1 signaling in hepatocelluar carcnoma. Biochim Biophys Acta, 1815, 214-23. |
2 | Hepatic fibrosis group of chinese society of hepatology (2002). consensus about evaluating hepatic fibrosis diagnosis and efficacy. Chinese J Hepatol, 10, 327-328. |
3 | Hemmann S, Graf J, Roderfeld M, et al (2007). Expression of MMPs and TIMPs in liver fibrosis-asystematic review with special emphasis on anti-fibrotic strategies. J Hepatol, 46, 955-75. DOI |
4 | Jiang YF, Huang F, Zhang JJ, et al (2011). RNA interference targets on connective tissue growth factor and tissue inhibitor tissue inhibtor of metalloproteinase-1 in vitro. J Clin Hepatol, 14, 246-8. |
5 | Jiang YF, Liu JQ, Zhang JJ, et al (2011). Construction of two different hepatic fibrosis-related cytokines shRNA recombinant plasmid. Chongqing Med, 40, 2341-2. |
6 | Jiang YF, Zhou DJ, Zhang JJ, et al (2012). Construction of dual RNA interference plasmid of hepatic fibrosis-related cytokines and study on transfection of hepatic stellate cells. J Clin Hepatol, 15, 516-9. |
7 | Kuang SL, Hu B (2008). Development of study on model of hepatic fibrosis in rats. Laboratory Animal Comparative Med, 28, 62-66. |
8 | Lee UE, Friedman SL (2011). Mechanisms of hepatic fibrogenisis. Best Pract Res Clin Gastroenterol, 25, 195-206. DOI |
9 | Rettiq GR,Behlke MA (2012). Progress toward in vivo use of siRNA-II. Mol Ther, 20, 483-512. DOI |
10 | Tache D,Boqdan F,Pisoschi C, et al (2011). Evidence for the involvement of TGF-1-CTGF axis in liver fibrogenisis secondary to hepatic viral infection. Rom J Morphol Embryol, 52, 409-12. |
11 | Xu LM (2010). Update on hepatic fibrosis research. J Clin Hepatol, 18, 563-565. |
12 | Yang J,Zheng J,Wu L, et al (2011). MDRG2 ameliorates hepatic fibrosis by inhibiting the TGF-1/Smad pathway and altering the MMP2/TIMP2 ratio in rats. PLoS One,6, 27710. DOI |
13 | Yan X,Chen YG (2011). Smad7:not only a regulator,but also a cross-talk mediator of TGF- signaling. Biochem J, 434, 1-10. DOI |